Insights into Clinical Trial Design, Adverse Events, Sexual Disfunction from Renal Cell Cancer and Treatments – Discussion with Prof Michael Staehler

In this episode of Med Insights Unleashed, hosts Zee and John welcome Michael Staehler MD Ph.D, Professor of Urology at the University of Munich and Head the Interdisciplinary Center for Renal Tumors at Ludwig-Maximilian University, Munich. to discuss renal cell carcinoma. He explains how patient selection and managing side effects, including sexual dysfunction, play critical roles in effective cancer treatment. The conversation also delves into the balance between drug efficacy and patient experience, highlighting the importance of patient communication and personalized care in clinical practice.

Leave a Reply